References
- Olefsky J M, Kimmerling G. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 1976; 271: 202–10
- Perley M, Kipnis D M. Effect of glucocorticoids on plasma insulin. N Engl J Med 1966; 274: 1237–41
- Rizza A R, Mandarino L J, Gerich J E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 1982; 54: 131–8
- Pagano G C, Cavallo-Perin C, Cassader M, Bruno A, Ozzello A, Masciola P, Dallomo A M, Imbibo B. An in vivo and in vitro study of the mechanism of prednisone-induced resistance in healthy subjects. J Clin Invest 1983; 72: 1814–20
- Kaihan S C, Adam P AJ. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. J Clin Endocrinol Metab 1975; 41: 600–10
- Billaudel B, Sutter B. Direct effect of corticoster-one upon insulin secretion studied by three different techniques. Horm Metab Res 1979; 11: 555–60
- Beard J C, Halter J B, Best J D, Pfeifer M A, Porte D., Jr. Dexamethasone-induced insulin resistance enhances B-cell responsiveness to glucose level in normal man. Am J Physiol 1984; 247: E592–6
- Brown J C, Dryburgh J R, Ross S A, Dupre J. Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res 1975; 31: 487–532
- Creutzfeldt W. The incretin concept today. Diabetologia 1979; 16: 75–85
- Murphy B EP. Some studies of the protein-binding of steroids and their applications to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 1967; 27: 973–90
- Heding L G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–6
- Heding L G. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8
- Groop P-H, Groop L, Fyhrquist F. Effect of serial test meals on immunoreactive gastric inhibitory polypeptide in non-insulin dependent diabetics and non-diabetic controls. Scand J Clin Lab Invest 1985; 45: 115–22
- Dixon W J. BMDP Statistical Software. University of California, Berkeley 1981
- Marco J, Calle C, Roman D, Diaz-Fierros M, Villanueva M L, Valverde I. Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med 1973; 288: 128–31
- Barseghian C, Levine R. Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas. Endocrinology 1980; 106: 547–52
- Chap Z, Jones R H, Chou J, Hartley C J, Entman M L, Field J B. Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. J Clin Invest 1986; 78: 1355–61
- Andersen D K, Elahi D, Brown J C, Tobin J D, Andres R. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 1978; 62: 152–61
- Verdonk C A, Rizza R A, Nelson R L, Go V LW, Gerich J E. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta-cell function. J Clin Invest 1980; 65: 1119–25
- Groop L, Luzi L, Melander A, Groop P H, Ratheiser K, Simonson D C, DeFronzo R. Different effects of glibenclamide and glipizide on insulin secretion and hepatic glucose production in normal and NIDD subjects. Diabetes, (in press)
- MacGregor I L, Gueller R, Watts H D, Meyer J H. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70: 190–6
- Ebert R, Arnold R, Creutzfeldt W. Lowering of fasting and food stimulated serum gastric inhibitory polypeptide (GIP) by glucagon. Gut 1977; 18: 121–7
- Service F J, Rizza R A, Westland R E, Hall L D, Gerich J E. Gastric inhibitory polypeptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 1984; 58: 1133–40